Prevalence of Intestinal Methanogen Overgrowth in Progressive Supranuclear Palsy: A Case-Control Study
Abstract
Objective Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder frequently accompanied by severe gastrointestinal dysfunction, particularly constipation. Although small intestinal bacterial overgrowth (SIBO) has been reported in several neurological diseases, intestinal microbial phenotypes in patients with PSP have not been systematically evaluated. This study aimed to assess the prevalence of intestinal methanogen overgrowth (IMO) and hydrogen-type SIBO in patients with PSP.Methods We conducted a cross-sectional case-control study to evaluate hydrogen- and methane-based breath test profiles in patients with PSP. Breath testing was performed in accordance with the North American Consensus criteria. The prevalence of hydrogen-type SIBO and IMO was compared between patients with PSP and healthy controls.Results Five patients with PSP and 33 healthy controls were included. IMO was identified more frequently in patients with PSP than in healthy controls (40.0% vs. 3.0%; P = 0.040). In contrast, hydrogen-type SIBO was not observed in either group. The mean Gastrointestinal Symptom Rating Scale (GSRS) score among patients with PSP was 29.4±5.9, and no clear association was observed between IMO positivity and gastrointestinal symptom severity or the presence of constipation.Conclusions Patients with PSP exhibited a distinct intestinal microbial phenotype characterized by methanogen predominance rather than hydrogen-type SIBO. Although limited by the small sample size, this pilot study provides novel insights into the gut microbial characteristics of PSP and suggests that qualitative alterations in the small intestinal microbiota and motility may contribute to PSP-associated gastrointestinal dysfunction.
Related
- Intestinal Methanogen Overgrowth in Parkinson's Disease Reflects Constipation Physiology: A Matched Cohort Study
- Longitudinal digital speech assessment in progressive supranuclear palsy
- Global perspectives on dietary management of small intestinal bacterial overgrowth (SIBO): a systematic review of clinical guidelines, consensus statements and expert recommendations
- Clinical and Epidemiological Profile of Progressive Supranuclear Palsy in a Colombian Referral Center: A Retrospective Cohort Study
- Selective white matter tract vulnerability associated with tau burden in progressive supranuclear palsy and Alzheimer’s disease
BibTeX
@article{yamazaki2026prevalence,
title = {{Prevalence of Intestinal Methanogen Overgrowth in Progressive Supranuclear Palsy: A Case-Control Study}},
author = {Shun Yamazaki and Kentaro Tominaga and Kotaro Watanabe and Tsuyoshi Matsubara and Takanori Igarashi and Takuya Wakabayashi and Hanako Yamazaki and Kunihiko Yokoyama and Yuichi Kojima and Yuzo Kawata and Kazuya Takahashi and Hiroyuki Abe and Akira Sakamaki and Takanobu Ishiguro and Osamu Onodera and Shuji Terai},
journal = {Internal Medicine},
year = {2026},
month = sep,
doi = {10.2169/internalmedicine.7712-26},
url = {https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7712-26/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Prevalence of Intestinal Methanogen Overgrowth in Progressive Supranuclear Palsy: A Case-Control Study
AU - Shun Yamazaki
AU - Kentaro Tominaga
AU - Kotaro Watanabe
AU - Tsuyoshi Matsubara
AU - Takanori Igarashi
AU - Takuya Wakabayashi
AU - Hanako Yamazaki
AU - Kunihiko Yokoyama
AU - Yuichi Kojima
AU - Yuzo Kawata
AU - Kazuya Takahashi
AU - Hiroyuki Abe
AU - Akira Sakamaki
AU - Takanobu Ishiguro
AU - Osamu Onodera
AU - Shuji Terai
PY - 2026
DA - 2026/09/22
JO - Internal Medicine
DO - 10.2169/internalmedicine.7712-26
UR - https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_7712-26/_article
AB - Objective Progressive supranuclear palsy (PSP) is a rare neurodegenerative disorder frequently accompanied by severe gastrointestinal dysfunction, particularly constipation. Although small intestinal bacterial overgrowth (SIBO) has been reported in several neurological diseases, intestinal microbial phenotypes in patients with PSP have not been systematically evaluated. This study aimed to assess the prevalence of intestinal methanogen overgrowth (IMO) and hydrogen-type SIBO in patients with PSP.Methods We conducted a cross-sectional case-control study to evaluate hydrogen- and methane-based breath test profiles in patients with PSP. Breath testing was performed in accordance with the North American Consensus criteria. The prevalence of hydrogen-type SIBO and IMO was compared between patients with PSP and healthy controls.Results Five patients with PSP and 33 healthy controls were included. IMO was identified more frequently in patients with PSP than in healthy controls (40.0% vs. 3.0%; P = 0.040). In contrast, hydrogen-type SIBO was not observed in either group. The mean Gastrointestinal Symptom Rating Scale (GSRS) score among patients with PSP was 29.4±5.9, and no clear association was observed between IMO positivity and gastrointestinal symptom severity or the presence of constipation.Conclusions Patients with PSP exhibited a distinct intestinal microbial phenotype characterized by methanogen predominance rather than hydrogen-type SIBO. Although limited by the small sample size, this pilot study provides novel insights into the gut microbial characteristics of PSP and suggests that qualitative alterations in the small intestinal microbiota and motility may contribute to PSP-associated gastrointestinal dysfunction.
SN - 1349-7235
SN - 0918-2918
ER -